NCCN Guidelines Insights: Bone Cancer, Version 2.2017

J. Sybil Biermann(University of Michigan–Ann Arbor), Warren Chow(City Of Hope National Medical Center), Damon R. Reed(Moffitt Cancer Center), David R. Lucas(University of Michigan–Ann Arbor), Douglas R. Adkins(Jewish Hospital), Mark Agulnik(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Robert S. Benjamin(The University of Texas MD Anderson Cancer Center), Brian E. Brigman(Duke Cancer Institute), G. Thomas Budd(Cancer Institute (WIA)), William T. Curry(Massachusetts General Hospital), Aarati Didwania(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Nicola Fabbri(Memorial Sloan Kettering Cancer Center), Francis J. Hornicek(Harvard University Press), Joseph Kuechle(Roswell Park Comprehensive Cancer Center), Dieter M. Lindskog(Yale Cancer Center), Joel Mayerson(The Ohio State University), Sean V. McGarry(Fred and Pamela Buffett Cancer Center), Lynn Million(Stanford University), Carol D. Morris(Johns Hopkins University), Sujana Movva(Fox Chase Cancer Center), Richard J. O’Donnell(UCSF Helen Diller Family Comprehensive Cancer Center), R. Lor Randall(Huntsman Cancer Institute), Peter S. Rose(WinnMed), Victor M. Santana(University of Tennessee Health Science Center), Robert L. Satcher(The University of Texas MD Anderson Cancer Center), Herbert S. Schwartz(Vanderbilt University), Herrick J. Siegel(University of Alabama at Birmingham), Katherine A. Thornton(Dana-Farber Brigham Cancer Center), Víctor M. Villalobos(University of Colorado Denver), Mary Anne Bergman(National Comprehensive Cancer Network), Jillian L. Scavone(National Comprehensive Cancer Network)
Journal of the National Comprehensive Cancer Network
February 1, 2017
Cited by 298Open Access
Full Text

Abstract

The NCCN Guidelines for Bone Cancer provide interdisciplinary recommendations for treating chordoma, chondrosarcoma, giant cell tumor of bone, Ewing sarcoma, and osteosarcoma. These NCCN Guidelines Insights summarize the NCCN Bone Cancer Panel's guideline recommendations for treating Ewing sarcoma. The data underlying these treatment recommendations are also discussed.


Related Papers

No related papers found

Powered by citation graph analysis